| Literature DB >> 35165557 |
Poonam Arora1, Hari Prasad1, Nishant Ranjan1, Aadya Pillai1, Naveen Joseph1.
Abstract
Acute fever is a common worldwide issue among patients presenting to the emergency department. Main tropical fevers presenting as acute fever are malaria, dengue fever, typhoid, scrub typhus, and leptospirosis. Scrub typhus is a zoonotic disease caused by Orientia tsutsugamushi, which is endemic in many parts of India. Its clinical presentation varies significantly from undifferentiated fever and fever with thrombocytopenia to meningoencephalitis. Persistent hypoglycemia in scrub typhus has not yet been reported. Here we report a case of a 27-year-old male who presented with altered mental status after seven days of scrub typhus diagnosis. Diagnosis of hypoglycemia (random blood sugar of 37 mg/dL) was made at triage. Altered mental status responded to dextrose, but despite meals and treatment, hypoglycemia persisted. The cause for persistent hypoglycemia remained unexplained as most laboratory panels for hypoglycemia were either normal or did not fit into a particular cause.Entities:
Keywords: blood sugar; hypoglycemia; meningoencephalitis; orientia tsutsugamushi; scrub typhus
Year: 2022 PMID: 35165557 PMCID: PMC8829456 DOI: 10.7759/cureus.21098
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Initial laboratory parameters
| Parameters | Results | Reference range |
| Hemoglobin | 12.7 g/dL (7.88 mmol/L) | 12–15 g/dL (7.45–9.31 mmol/L) |
| Red Blood Cell Count (RBC) | 4.01 × 106/mcL (4.01 × 1012/L) | 3.8–5.2 × 106/mcL (3.8–5.2 × 1012/L) |
| White Blood Cell Count (WBC) | 8.7 × 103/mcL (8.7 × 109/L) | 4–11 × 103/mcL (4–11 × 109/L) |
| Platelets | 34 × 103/mcL (34 × 109/L) | 150–400 × 103/mcL (150–400 × 109/L) |
| Total bilirubin | 2.2 mg/dL (37.62 µmol/L) | 0.3–1.2 mg/dL (5.13–20.52 µmol/L) |
| Direct bilirubin | 0.8 mg/dL (37.62 µmol/L) | 0–0.2 mg/dL (0–3.42 µmol/L) |
| Alanine aminotransferase (ALT) | 88 U/L (1.46 µkat/L) | 0–35 U/L (0–0.58 µkat/L) |
| Aspartate aminotransferase (AST) | 109 U/L (1.81 µkat/L) | 0–35 U/L (0–0.58 µkat/L) |
| Alkaline phosphatase (ALP) | 742 U/L (12.32 µkat/L) | 30–120 U/L (0.5–2 µkat/L) |
| Serum Albumin | 3.5 g/dL (35 g/L) | 3.5–5.2 g/dL (35–52 g/L) |
| Urea | 116 mg/dL (41.41 mmol/L) | 17–43 mg/dL (2.83–7.15 mmol/L) |
| Creatinine | 2.56 mg/dL (226.36 µmol/L) | 0.55–1.02mg/dL (48.63–90.19 µmol/L) |
| Sodium | 135 mEq/L (135 mmol/L) | 136–146 mEq/L (136–146 mmol/L) |
| Potassium | 4.1 mEq/L (4.1 mmol/L) | 3.5–5.1 mEq/L (3.5–5.1 mmol/L) |
Blood sugar monitoring in mg/dL during admission
| Time | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 |
| 6 am | 70 | 96 | 72 | 100 | 75 | 70 | |
| 8 am | 90 | 70 | 80 | 92 | 58 | 80 | |
| 10 am | 56 | 101 | 88 | 67 | 80 | 56 | |
| 12 pm | 100 | 104 | 76 | 82 | 83 | 70 | |
| 2 pm | 74 | 76 | 62 | 84 | 86 | 92 | |
| 4 pm | 32 | 68 | 92 | 70 | 51 | 98 | |
| 6 pm | 98 | 79 | 94 | 65 | 80 | ||
| 8 pm | 76 | 68 | 70 | 88 | 73 | ||
| 10 pm | 70 | 94 | 64 | 82 | 81 | ||
| 12 am | 37 | 41 | 66 | 88 | 63 | 91 | |
| 2 am | 24 | 107 | 80 | 100 | 79 | 64 | |
| 4 am | 87 | 101 | 96 | 68 | 92 | 74 |
Hypoglycemia panel of investigations
T3, triiodothyronine; T4, thyroxine
| Test | Results | Reference range |
| Fasting plasma glucose | 58 mg/dL | 70–110 mg/dL |
| Free T3 | 4.86 pg/mL | 2–4.4 pg/mL |
| Free T4 | 1.47 ng/dL | 0.85–1.86 ng/dL |
| Growth hormone | 2.45 ng/mL | ≤ 10 ng/mL |
| Cortisol | 9.20 µg/dL | 5–25 µg/dL |
| Insulin | 2.39 mU/L | 2.6–37.6 mU/L |
| C peptide | 0.86 ng/mL | 1.10–4.4 ng/mL |
| Insulin-C peptide molar ratio | 0.0604 | 1 |